An oral apoJ peptide renders HDL anti-inflammatory in mice and monkeys and dramatically reduces atherosclerosis in apoE null mice

被引：0
|
作者：
Navab, M
Anantharamaiah, GM
Alabama, U
Reddy, ST
Van Lenten, BJ
Wagner, AC
Hama, SY
Hough, GP
Garber, DW
Mishra, VK
Palgunachari, MN
Fogelman, AM
机构：
[1] CHS, Los Angeles, CA USA
[2] Univ Alabama, Birmingham, AL 35233 USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
902
引用
收藏
页码：U227 / U227
页数：1
相关论文
共 50 条
  • [1] An oral ApoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Wagner, AC
    Hama, S
    Hough, G
    Bachini, E
    Garber, DW
    Mishra, VK
    Palgunachari, MN
    Fogelman, AM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) : 1932 - 1937
  • [2] Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Hama, S
    Hough, G
    Frank, JS
    Grijalva, VR
    Ganesh, VK
    Mishra, VK
    Palgunachari, MN
    Fogelman, AM
    CIRCULATION RESEARCH, 2005, 97 (06) : 524 - 532
  • [3] Oral D-4F dramatically synergizes with oral pravastatin to reduce atherosclerosis in ApoE null mice
    Anantharamalah, GM
    Navab, M
    Hama, S
    Hough, G
    Reddy, ST
    Frank, JS
    Handattu, S
    Garber, DW
    Fogelman, AM
    CIRCULATION, 2004, 110 (17) : 37 - 37
  • [4] An oral synthetic phospholipid (DGP) raises HDL-cholesterol levels, improves HDL function, and dramatically reduces atherosclerosis in apo E null mice
    Navab, M
    Hama, SY
    Teshome, M
    Hough, G
    Fogelman, AM
    CIRCULATION, 2002, 106 (19) : 77 - 78
  • [5] Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice
    Srivastava, Sanjay
    Sithu, Srinivas D.
    Vladykovskaya, Elena
    Haberzettl, Petra
    Hoetker, David J.
    Siddiqui, Maqsood A.
    Conklin, Daniel J.
    D'Souza, Stanley E.
    Bhatnagar, Aruni
    ATHEROSCLEROSIS, 2011, 215 (02) : 301 - 308
  • [6] Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice
    Burleigh, ME
    Babaev, VR
    Patel, MB
    Crews, BC
    Remmel, RP
    Morrow, JD
    Oates, JA
    Marnett, LJ
    Fazio, S
    Linton, MF
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (03) : 334 - 342
  • [7] PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
    Tordjman, K
    Bernal-Mizrachi, C
    Zemany, L
    Weng, S
    Feng, C
    Zhang, FJ
    Leone, TC
    Coleman, T
    Kelly, DP
    Semenkovich, CF
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (08): : 1025 - 1034
  • [8] Acai juice attenuates atherosclerosis in ApoE deficient mice through antioxidant and anti-inflammatory activities
    Xie, Chenghui
    Kang, Jie
    Burris, Ramona
    Ferguson, Matthew E.
    Schauss, Alexander G.
    Nagarajan, Shanmugam
    Wu, Xianli
    ATHEROSCLEROSIS, 2011, 216 (02) : 327 - 333
  • [9] Anti-inflammatory lipoxin A4 attenuates atherosclerosis progression in diabetic ApoE-/- mice
    Brennan, E.
    McClelland, A.
    Mohan, M.
    Gray, S.
    Pickering, R.
    Tikellis, C.
    Jandeleit-Dahm, K.
    Cooper, M.
    Godson, C.
    Kantharidis, P.
    DIABETOLOGIA, 2016, 59 : S527 - S527
  • [10] Salicylamine, A γ-ketoaldehyde Scavenger, Improves HDL Function and Reduces Atherosclerosis in Apoe Deficient Mice
    Huang, Jiansheng
    Yancey, Patricia
    Ding, Lei
    Zhang, Youmin
    Oates, John
    Amarnath, Venkataraman
    Roberts, Jackson
    Davies, Sean
    Linton, MacRae F.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
12345